Skip to main content

Table 1 Clinical and serum biochemical parameters of subjects

From: Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry

 

NAFLD

(n = 112)

Control

(n = 112)

P value

Gender (M/F)

68/44

62/50

 

Age

46 ± 14

41 ± 15

0.538

Height (cm)

169.42 ± 8.73

170.59 ± 8.07

0.615

Weight (kg)

77.55 ± 13.49

62.37 ± 8.05

0.001**

BMI (kg/m2)

27.1(24–28.55)

21.46(20.57–22.54)

0.001**

Systolic pressure (mmHg)

125.41(120–130)

123.59(115–132)

0.375

Diastolic pressure (mmHg)

79.74(75–85)

77.63(74–81)

0.183

Waist circumference (cm)

91.75 ± 11.76

72.04 ± 5.96

0.001

Heart rate (BPM)

68.68 ± 5.09

68.80 ± 4.88

0.851

Smoking (n)

62

83

0.154

Drinking (n)

  

0.916

 None

10

6

 

 Light

38

43

 

 Moderate

64

63

 

Blood glucose (mmol/L)

5.12 ± 0.35

5.21 ± 0.42

0.38

TB (umol/L)

12.74 ± 2.54

12.89 ± 3.62

0.862

DB (umol/L)

2.32 ± 0.5

2.23 ± 0.95

0.669

TP (g/L)

73.52 ± 4.71

73.11 ± 5.4

0.769

ALB (umol/L)

41.85 ± 2.99

41.37 ± 5.46

0.689

CHE (U/L)

8400.78 ± 1353.66

7694.52 ± 1640.95

0.09

ALT (U/L)

20.67 ± 11.67

28.04 ± 19.13

0.093

AST (U/L)

23.93 ± 6.49

27.7 ± 13.02

0.183

ALP (U/L)

76.96 ± 18.08

84.33 ± 22.15

0.186

γ-GT(U/L)

23.74 ± 11.8

31.59 ± 22.75

0.118

TC (mmol/L)

5.67 ± 1.22

4.57 ± 0.8

0.001**

TG (mmol/L)

0.83 ± 0.96

1.24 ± 0.56

0.008*

HDL-C (mmol/L)

0.98 ± 0.18

1.49 ± 0.35

0.002*

LDL-C (mmol/L)

4.89 ± 0.73

3.65 ± 1.01

0.002*